April 04,2007
Grassley Seeks Marketing and Safety Documents from Major Drug Maker
WASHINGTON — Sen. Chuck Grassley is asking the drug maker, Eli Lilly and Company, for information related to the risks and marketing of the anti-psychotic drug Zyprexa. Grassley made this request in response to allegations that the company downplayed safety risks and engaged in other improper marketing practices that may be jeopardizing patients’ health.
The text of Grassley’s letter can be found in the printer-friendly version of this news release.
###
Next Article Previous Article
Recent News
- Wyden, Warner Call on Trump to Help Seniors When Insurance Companies Drop Doctors from Their Plans
- Continuing Epstein Investigation, Wyden Releases New Analysis Detailing How Top JPMorgan Chase Executives Enabled Epstein’s Sex Trafficking Operation
- Wyden Statement on Public Charge Rule
- Wyden Report Shows How GOP Health Tax Scheme Funnels Money to Big Banks and Insurance Companies While Sticking Families with High Costs
- Wyden Statement on the Epstein Bill’s Passage and Treasury’s Epstein File